Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basel Medical GroupBMGL -7.17%17 PB Ratio is 1.83 as of Jul. 16, 2026, which is 66% below its 10-year median of 5.36. GuruFocus rates BMGL with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 610 Healthcare Providers & Services companies, Basel Medical Group ranks better than 50.82% on this metric.
Basel Medical Group Ltd stock PB Ratio (=1.97) is close to 2-year low of 1.97.
The historical rank and industry rank for Basel Medical Group's PB Ratio or its related term are showing as below:
BMGL'
s PB Ratio Range Over the Past 10 Years
Min: 1.77 Med: 5.36 Max: 20.06
Current: 1.83
During the past 4 years, Basel Medical Group's highest PB Ratio was 20.06. The lowest was 1.77. And the median was 5.36.
BMGL's PB Ratio is ranked better than 50.82% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.01
vs BMGL: 1.83
During the past 12 months, Basel Medical Group's average Book Value Per Share Growth Rate was -11.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 15.90% per year.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Basel Medical Group was 15.90% per year. The lowest was 15.90% per year. And the median was 15.90% per year.
Back to Basics: PB Ratio
Basel Medical Group (NAS:BMGL) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Basel Medical Group PB Ratio Related Terms
Basel Medical Group PB Ratio Historical Data
* Premium members only.
The historical data trend for Basel Medical Group's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Basel Medical Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basel Medical Group PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basel Medical Group's PB Ratio distribution charts can be found below:
* The bar in red indicates where Basel Medical Group's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Basel Medical Group (BMGL) has a PB Ratio of 1.83 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Basel Medical Group and its competitors. This is 66% below median its historical median of 5.36. Over the past decade, Basel Medical Group's PB Ratio has ranged from 1.77 to 20.06. According to the industry distribution chart, Basel Medical Group ranks #300 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 49.2%.
Is Basel Medical Group's PB Ratio too high?
Basel Medical Group's current PB Ratio of 1.83 is 66% below median its 10-year median of 5.36. Over the past 10 years, this metric has ranged from a low of 1.77 to a high of 20.06. The Healthcare Providers & Services industry median PB Ratio is 2.01. Basel Medical Group's value of 1.83 is 9% below this industry median. Based on the distribution chart, Basel Medical Group ranks #300 out of 610 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Basel Medical Group has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Basel Medical Group's PB Ratio compare to AMS and HLYK?
According to the Healthcare Providers & Services industry distribution chart, Basel Medical Group ranks #300 out of 610 companies for PB Ratio. This puts Basel Medical Group in the upper half of its industry. The industry median PB Ratio is 2.01. Basel Medical Group's value of 1.83 is 9% below this benchmark. Historically, Basel Medical Group's own PB Ratio has ranged from 1.77 to 20.06 over the past decade. While the company's 10-year median is 5.36 vs. the industry median of 2.01, Basel Medical Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.01, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basel Medical Group's current PB Ratio of 1.83 is 9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Basel Medical Group and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basel Medical Group's current PB Ratio is 1.83, which is 66% below median its own 10-year median of 5.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basel Medical Group stock overvalued right now?
Basel Medical Group (BMGL) has a current PB Ratio of 1.83. The current PB Ratio is 1.83, which is 66% below median its 10-year median of 5.36 and 9% below the Healthcare Providers & Services industry median of 2.01. Basel Medical Group's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Basel Medical Group (BMGL), the current PB Ratio is 1.83 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. The services provided by clinics include, but are not limited to, consultation, medical diagnosis and medical or surgical treatments for orthopedic, trauma, sports medicine, general practice, health screening, mental health, women's health and neurosurgical conditions and clinics are equipped with the facilities needed to perform a variety of procedures on site and minor surgical services. Key revenue is generated from Singapore.
17GF Score
Get the complete analysis for BMGL
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BMGL has been successfully added to your 
